Life Science Product News

The Bio-Plex Pro Human Cytokine Screening Panel is a multiplex assay that can accurately and reproducibly quantify up to 48 analytes involved in complex biological networks in a single assay.

A number of studies powered by ddPCR exploring epigenetics and immunotherapy will be presented at this year’s AACR meeting.

In January, reports were published regarding two security flaws known as "Spectre" and "Meltdown." These vulnerabilities can potentially affect modern processors that are embedded in any type of computing device.

The NGC Fraction Collector for NGC Chromatography Systems offers multivessel collection modes that adapt for collection levels from small to process scale

How Droplet Digital PCR provides early detection of transplant rejection and delivers absolute quantification of gene expression to investigate cancer.

Bio-Rad’s pre-conference workshop at the BioProcess International Conference & Exhibition to feature new approaches and tools that purify diverse biomolecules and quantify impurities in downstream processes.

Researchers presented evidence of clinical potential for how circulating tumor DNA, measured by ddPCR, could be used as a biomarker to identify pseudoprogression and measure early indicators of response in immuno-oncology therapies.

Bio-Rad’s ddPCR™ Genome Edit Detection Assays are the first tests to characterize edits generated by CRISPR-Cas9 or other genome editing tools using Droplet Digital PCR, enabling fast, sensitive, and cost-effective quantification of CRISPR efficiency.

Only CFX Maestro provides researchers with an integrated suite of real-time PCR tools, making data collection, statistical analysis, and design of publication-ready graphs easy.

Microsoft operating systems recently experienced a security vulnerability resulting from a widespread ransomware attack through Microsoft’s network environments on a global scale. Bio-Rad’s internal IT team has evaluated the technical details of the Microsoft security update and has approved the patch.